Picture of Abbott Laboratories logo

ABT Abbott Laboratories Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-8.83%
3m-7.49%
6m-6.65%
1yr-13.56%
Volume Change (%)
10d/3m+47.02%
Price vs... (%)
52w High-9.1%
50d MA-4.08%
200d MA+4.08%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)23.48
PEG Ratio (f)1.09
EPS Growth (f)27.54%
Dividend Yield (f)1.94%
Valuation (ttm)IndustryMarket
Price to Book Value4.97
Price to Tang. Book31.41
Price to Free Cashflow37.92
Price to Sales4.78
EV to EBITDA20.6

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital10.84%
Return on Equity15.2%
Operating Margin16.05%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m31,90434,60843,07543,65340,10942,006.5945,007.125.58%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+40.34+17.68+61.46+2.12-16.76+34.14+10.84n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Abbott Laboratories EPS forecast chart

Profile Summary

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
March 6th, 1900
Public Since
March 1st, 1937
No. of Shareholders
32,449
No. of Employees
114,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
1,735,184,289

ABT Share Price Performance

Latest News for ABT

Upcoming Events for ABT

Dividend For ABTT34.SA - 0.2281 BRL

Dividend For ABT.BA - 0.1375 USD

Dividend For ABT.N - 0.5500 USD

Q1 2024 Abbott Laboratories Earnings Release

Abbott Laboratories Annual Shareholders Meeting

Abbott Laboratories Annual Shareholders Meeting

Q2 2024 Abbott Laboratories Earnings Release

Similar to ABT

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

Picture of Avanos Medical logo

Avanos Medical

us flag iconNew York Stock Exchange

FAQ